Dextrose 5% in water (D5W) — Competitive Intelligence Brief

Dextrose 5% in water (D5W) (Dextrose 5% in water (D5W)) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid / Crystalloid solution. Area: Supportive care / Fluid and electrolyte management.

marketed Intravenous fluid / Crystalloid solution Supportive care / Fluid and electrolyte management Small molecule

Target snapshot

Dextrose 5% in water (D5W) (Dextrose 5% in water (D5W)) — Hospital for Special Surgery, New York. Dextrose 5% in water provides a source of glucose and free water for intravenous hydration and caloric supplementation.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Dextrose 5% in water (D5W) TARGET	Dextrose 5% in water (D5W)	Hospital for Special Surgery, New York	marketed	Intravenous fluid / Crystalloid solution
Balanced crystalloid	Balanced crystalloid	National Taiwan University Hospital	marketed	Intravenous fluid / Crystalloid solution
Isotonic crystalloids	Isotonic crystalloids	Marie Kristine Jessen, MD	marketed	Intravenous fluid / Crystalloid solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid / Crystalloid solution class)

1. Hospital for Special Surgery, New York · 1 drug in this class
2. Marie Kristine Jessen, MD · 1 drug in this class
3. National Taiwan University Hospital · 1 drug in this class